Janux Therapeutics JANX
NASDAQ JANX
$16.76 -0.17 (-0.97%)
As of: Oct 22, 2026 · 11:17 AM EDT

Janux Therapeutics (JANX) Other financing activities (2025)

Updated

Analysis

Janux Therapeutics (JANX) Other financing activities (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.45 Bn 1,141.04 Bn 19.71 Bn
2 Johnson & Johnson 637.59 Bn 556.11 Bn 17.26 Bn
3 AbbVie 504.05 Bn 477.16 Bn 12.70 Bn
4 Merck 377.18 Bn 331.56 Bn 12.21 Bn
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn
7 Amgen 241.83 Bn 197.23 Bn 7.24 Bn
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn
9 Pfizer 172.51 Bn 119.15 Bn 10.94 Bn
10 Janux Therapeutics 1.05 Bn -2.83 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -347,000.00
API Access

Janux Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=JANX&period=max&api_key=YOUR_API_KEY